vs
Forestar Group Inc.（FOR）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Bio-Techne的季度营收约是Forestar Group Inc.的1.1倍（$295.9M vs $273.0M），Bio-Techne净利率更高（12.8% vs 5.6%，领先7.2%），Forestar Group Inc.同比增速更快（9.0% vs -6.4%），过去两年Bio-Techne的营收复合增速更高（4.2% vs -9.6%）
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
FOR vs TECH — 直观对比
营收规模更大
TECH
是对方的1.1倍
$273.0M
营收增速更快
FOR
高出15.4%
-6.4%
净利率更高
TECH
高出7.2%
5.6%
两年增速更快
TECH
近两年复合增速
-9.6%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $273.0M | $295.9M |
| 净利润 | $15.4M | $38.0M |
| 毛利率 | 20.1% | 64.6% |
| 营业利润率 | 7.6% | 18.4% |
| 净利率 | 5.6% | 12.8% |
| 营收同比 | 9.0% | -6.4% |
| 净利润同比 | -6.7% | 68.3% |
| 每股收益（稀释后） | $0.30 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FORTECH
| Q4 25 | $273.0M | $295.9M | ||
| Q3 25 | $670.5M | — | ||
| Q2 25 | $390.5M | $317.0M | ||
| Q1 25 | $351.0M | $316.2M | ||
| Q4 24 | $250.4M | $297.0M | ||
| Q3 24 | $551.3M | $289.5M | ||
| Q2 24 | $318.4M | $306.1M | ||
| Q1 24 | $333.8M | $303.4M |
净利润FORTECH
| Q4 25 | $15.4M | $38.0M | ||
| Q3 25 | $86.9M | — | ||
| Q2 25 | $32.9M | $-17.7M | ||
| Q1 25 | $31.6M | $22.6M | ||
| Q4 24 | $16.5M | $34.9M | ||
| Q3 24 | $81.5M | $33.6M | ||
| Q2 24 | $38.7M | $40.6M | ||
| Q1 24 | $45.0M | $49.1M |
毛利率FORTECH
| Q4 25 | 20.1% | 64.6% | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 20.4% | 62.7% | ||
| Q1 25 | 22.6% | 67.9% | ||
| Q4 24 | 22.0% | 65.3% | ||
| Q3 24 | 23.9% | 63.2% | ||
| Q2 24 | 22.5% | 66.4% | ||
| Q1 24 | 24.9% | 67.4% |
营业利润率FORTECH
| Q4 25 | 7.6% | 18.4% | ||
| Q3 25 | 16.9% | — | ||
| Q2 25 | 11.2% | -7.5% | ||
| Q1 25 | 11.6% | 12.2% | ||
| Q4 24 | 8.7% | 16.0% | ||
| Q3 24 | 19.7% | 13.8% | ||
| Q2 24 | 16.2% | 15.0% | ||
| Q1 24 | 17.6% | 22.1% |
净利率FORTECH
| Q4 25 | 5.6% | 12.8% | ||
| Q3 25 | 13.0% | — | ||
| Q2 25 | 8.4% | -5.6% | ||
| Q1 25 | 9.0% | 7.1% | ||
| Q4 24 | 6.6% | 11.7% | ||
| Q3 24 | 14.8% | 11.6% | ||
| Q2 24 | 12.2% | 13.3% | ||
| Q1 24 | 13.5% | 16.2% |
每股收益（稀释后）FORTECH
| Q4 25 | $0.30 | $0.24 | ||
| Q3 25 | $1.70 | — | ||
| Q2 25 | $0.65 | $-0.11 | ||
| Q1 25 | $0.62 | $0.14 | ||
| Q4 24 | $0.32 | $0.22 | ||
| Q3 24 | $1.59 | $0.21 | ||
| Q2 24 | $0.76 | $0.26 | ||
| Q1 24 | $0.89 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $211.7M | $172.9M |
| 总债务越低越好 | $793.2M | $260.0M |
| 股东权益账面价值 | $1.8B | $2.0B |
| 总资产 | $3.2B | $2.5B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资FORTECH
| Q4 25 | $211.7M | $172.9M | ||
| Q3 25 | $379.2M | — | ||
| Q2 25 | $189.2M | $162.2M | ||
| Q1 25 | $174.3M | $140.7M | ||
| Q4 24 | $132.0M | $177.5M | ||
| Q3 24 | $481.2M | $187.5M | ||
| Q2 24 | $359.2M | $152.9M | ||
| Q1 24 | $416.2M | $145.3M |
总债务FORTECH
| Q4 25 | $793.2M | $260.0M | ||
| Q3 25 | $802.7M | — | ||
| Q2 25 | $872.8M | $346.0M | ||
| Q1 25 | $872.5M | $330.0M | ||
| Q4 24 | $806.8M | $300.0M | ||
| Q3 24 | $706.4M | $300.0M | ||
| Q2 24 | $706.1M | $319.0M | ||
| Q1 24 | $705.7M | $389.0M |
股东权益FORTECH
| Q4 25 | $1.8B | $2.0B | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.7B | $1.9B | ||
| Q1 25 | $1.6B | $2.0B | ||
| Q4 24 | $1.6B | $2.1B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.5B | $2.1B | ||
| Q1 24 | $1.5B | $2.0B |
总资产FORTECH
| Q4 25 | $3.2B | $2.5B | ||
| Q3 25 | $3.1B | — | ||
| Q2 25 | $3.1B | $2.6B | ||
| Q1 25 | $3.0B | $2.6B | ||
| Q4 24 | $3.0B | $2.7B | ||
| Q3 24 | $2.8B | $2.7B | ||
| Q2 24 | $2.7B | $2.7B | ||
| Q1 24 | $2.6B | $2.7B |
负债/权益比FORTECH
| Q4 25 | 0.44× | 0.13× | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.52× | 0.18× | ||
| Q1 25 | 0.53× | 0.16× | ||
| Q4 24 | 0.50× | 0.14× | ||
| Q3 24 | 0.44× | 0.14× | ||
| Q2 24 | 0.47× | 0.15× | ||
| Q1 24 | 0.48× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-157.0M | — |
| 自由现金流经营现金流 - 资本支出 | $-157.1M | — |
| 自由现金流率自由现金流/营收 | -57.5% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | -10.19× | — |
| 过去12个月自由现金流最近4个季度 | $93.0M | — |
8季度趋势，按日历期对齐
经营现金流FORTECH
| Q4 25 | $-157.0M | — | ||
| Q3 25 | $256.3M | — | ||
| Q2 25 | $15.8M | $98.2M | ||
| Q1 25 | $-19.8M | $41.1M | ||
| Q4 24 | $-450.0M | $84.3M | ||
| Q3 24 | $119.2M | $63.9M | ||
| Q2 24 | $-61.7M | $75.5M | ||
| Q1 24 | $-59.2M | $81.0M |
自由现金流FORTECH
| Q4 25 | $-157.1M | — | ||
| Q3 25 | $255.6M | — | ||
| Q2 25 | $15.0M | $93.3M | ||
| Q1 25 | $-20.5M | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | $118.4M | $54.7M | ||
| Q2 24 | $-62.3M | $57.5M | ||
| Q1 24 | $-59.8M | $64.5M |
自由现金流率FORTECH
| Q4 25 | -57.5% | — | ||
| Q3 25 | 38.1% | — | ||
| Q2 25 | 3.8% | 29.4% | ||
| Q1 25 | -5.8% | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | 21.5% | 18.9% | ||
| Q2 24 | -19.6% | 18.8% | ||
| Q1 24 | -17.9% | 21.3% |
资本支出强度FORTECH
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.2% | 3.2% | ||
| Q4 24 | 0.0% | 2.3% | ||
| Q3 24 | 0.1% | 3.2% | ||
| Q2 24 | 0.2% | 5.9% | ||
| Q1 24 | 0.2% | 5.4% |
现金转化率FORTECH
| Q4 25 | -10.19× | — | ||
| Q3 25 | 2.95× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | -0.63× | 1.82× | ||
| Q4 24 | -27.27× | 2.42× | ||
| Q3 24 | 1.46× | 1.90× | ||
| Q2 24 | -1.59× | 1.86× | ||
| Q1 24 | -1.32× | 1.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
